mk2 Biotechnologies develops, produces and investigates peptides and proteins using a synthesis technology, enabling their cost-efficient production for various applications.

mk2 Biotechnologies

Karamalz is a beverage company that offers various products including malt drinks and promotional items. Self-described as a quality provider, Karamalz also engages in cooking promotions.

Karamalz

mk2 Biotechnologies | 1,216 followers on LinkedIn. Peptides &amp; Proteins for Mass Applications | mk2 Biotechnologies develops, produces and investigates peptides &amp; proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides &amp; proteins for a broad range of applications.

CEO at mohemian

Florian Scholochow

think bigger and never give up!!

René Schmidt

Head of Business Development | Biochemistry, Biophysics, Strategic Business Development

Priya Gurumoorthy, Ph.D.

Senior Advisor / Organisationsentwickler/ Projektcoach/ Founding & Business Angel

Thomas Leitgeb

The Finance Days at the analytica were a great opportunity for our CEO Konstantinos Antonopoulos to have a chat with a lot of fantastic people from the broader space and to develop creative solutions on the spot. If you're still around Munich and want to meet up, let us know! #proteins #peptides Christian Gnam IZB - Innovation and Start-up Center Biotechnology

Don't miss the opportunity to meet Priya Gurumoorthy, Ph.D. at the Meat Evolution Leaders Summit in Barcelona on Feb 7th/8th to check out our newest developments on growth factors and many more bioactive proteins.

Metric
Company Name	mk2 Biotechnologies	Karamalz
Symbol
MSH ID	BIO:MK2	DE:KARAMALZ
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Goods
Industry	Biotechnology	Food and Beverage
Country	DE	DE
Stage
Employee Count
Website	mk2.bio	karamalz.de
LinkedIn	mk2biotechnologies	privatbrauerei-eichbaum-gmbh-&-co-kg
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MK2

BIO:MK2

mk2 Biotechnologies

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue